Sex as a predictor of response to cancer immunotherapy
Lancet Oncol
.
2018 Aug;19(8):e374.
doi: 10.1016/S1470-2045(18)30446-7.
Authors
Tao Zhang
1
,
Huixun Jia
2
,
Zhenyu Wu
3
Affiliations
1
Department of Biostatistics, School of Public Health, Shandong University, Jinan, China.
2
Clinical Statistics Center, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China.
3
Department of Biostatistics, School of Public Health, Fudan University, Shanghai 200032, China. Electronic address: zyw@fudan.edu.cn.
PMID:
30102224
DOI:
10.1016/S1470-2045(18)30446-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunotherapy*
Neoplasms*
Grants and funding
R01 HL136921/HL/NHLBI NIH HHS/United States
R21 CA198544/CA/NCI NIH HHS/United States